Comparing the Safety and Benefit of Natalizumab (Tysabri®) At-home Infusion vs At-hospital Infusion in Multiple Sclerosis
Clinical trial NCT04777539 · COMPLETED
Trial details
- NCT number
- NCT04777539
- Sponsor
- Nantes University Hospital
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2021-06-14
- Primary completion
- 2024-11-14
- Enrollment
- 295
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.